Provided by Tiger Fintech (Singapore) Pte. Ltd.

MaxCyte Inc

2.57
-0.0400-1.53%
Volume:545.52K
Turnover:1.41M
Market Cap:273.23M
PE:-6.56
High:2.68
Open:2.57
Low:2.53
Close:2.61
Loading ...

MaxCyte, Inc. MaxCyte, Inc. - Mxcr - Strategic Platform License With TG Therapeutics

THOMSON REUTERS
·
12 Feb

MaxCyte Inc - TG Therapeutics Obtains Rights to Use MaxCyte Technology

THOMSON REUTERS
·
12 Feb

MaxCyte to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025, and Participate in Upcoming Investor Conference

GlobeNewswire
·
07 Feb

MaxCyte Announces Executive Stock Transaction

TIPRANKS
·
31 Jan

Craig-Hallum Gives a Buy Rating to MaxCyte (MXCT)

TIPRANKS
·
30 Jan

MaxCyte acquires SeQure Dx for $4.5M at closing, sees accretion

TIPRANKS
·
30 Jan

MaxCyte Acquires Gene Editing Analytics Company SeQure Dx

MT Newswires Live
·
30 Jan

BRIEF-Maxcyte Buys Sequre Dx For $4.5 Million

Reuters
·
30 Jan

MaxCyte Inc - Pays $4.5 Million for Sequre Dx

THOMSON REUTERS
·
30 Jan

MaxCyte Inc - Additional $2.5 Million Contingent on Revenue Targets

THOMSON REUTERS
·
30 Jan

MaxCyte, Inc. MaxCyte, Inc. - Mxcr - MaxCyte® Acquires Sequre Dx

THOMSON REUTERS
·
30 Jan

MaxCyte® Acquires Sequre Dx to Broaden Cell Engineering Offerings With on-Target and off-Target Editing Assessments

THOMSON REUTERS
·
30 Jan

MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments

GlobeNewswire
·
30 Jan

BlackRock Increases Stake in MaxCyte, Inc.

TIPRANKS
·
29 Jan

Investors push MaxCyte (LON:MXCT) 9.7% lower this week, company's increasing losses might be to blame

Simply Wall St.
·
29 Jan

MaxCyte Sees Increase in BlackRock Holdings

TIPRANKS
·
22 Jan

BlackRock Increases Stake in MaxCyte to 7.57%

TIPRANKS
·
21 Jan

All You Need to Know About MaxCyte (MXCT) Rating Upgrade to Strong Buy

Zacks
·
16 Jan

BlackRock Increases Stake in MaxCyte, Inc.

TIPRANKS
·
16 Jan

What Is MaxCyte, Inc.'s (LON:MXCT) Share Price Doing?

Simply Wall St.
·
15 Jan